Anti-Mouse H-2Db (Clone B22/249) – Purified in vivo GOLD™ Functional Grade
Anti-Mouse H-2Db (Clone B22/249) – Purified in vivo GOLD™ Functional Grade
Product No.: B340
Clone B22/249 Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names H-2D; H2-D; H2-D1 Isotype Mouse IgG2a k Applications Cytotoxicity Assay , ELISA , FA , FC , IF , In vitro depletion , IP |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Mouse Recommended Isotype Controls Recommended Dilution Buffer Immunogen Mouse H-2Db Product Concentration ≥ 5.0 mg/ml Endotoxin Level ≤ 1.0 EU/mg as determined by the LAL method Purity ≥95% by SDS Page ⋅ ≥95% monomer by analytical SEC Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2-8°C Wet Ice Additional Applications Reported In Literature ? In vitro depletion, Cytotoxicity Assay, IP Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity B22.249.R1 activity is directed against mouse H-2Db. Background H-2, the murine major histocompatibility complex (MHC), is composed of a diverse group of antigens divided into class I and II proteins that function in immune response1. H-2Db is a class I MHC cell surface protein. MHC class I molecules bind peptides generated by the degradation of cytosolic proteins, and then display those peptides on the cell surface. Generally, these peptides are derived from normal metabolism, but they can also be derived from foreign proteins during viral infection or allotransplantation. For example, H-2Db plays a role in human papillomavirus infection2. When peptides are recognized as foreign, cytotoxic T lymphocytes specific to the MHC class I-peptide complex kill the presenting cell1. B22-249.R1 was generated by immunizing mice with spleen cells from allogeneic mice using the combination BSLB/k anti-C57BL/63. Spleen cells of the recipient mouse were hybridized with the P3-NS 1-Ag4 myeloma cell line and screened using cytotoxic and hemagglutination assays. B22-249.R1 is also known as H-2.m2 in the literature4. Antigen Distribution H-2Db is expressed on the cell surface of lymphocytes. Ligand/Receptor CD3/TCR, CD8 NCBI Gene Bank ID UniProt.org P01899 Research Area Immunology Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone B22/249 is a monoclonal antibody targeting mouse H-2Db, an MHC class I molecule, and is used in in vivo mouse studies primarily for immunological research applications such as cytotoxicity assays, in vivo cell depletion, and immunoprecipitation. Key usage contexts:
Important technical details:
In summary, clone B22/249 is a well-established tool for modulating and analyzing mouse MHC class I–mediated immune responses in vivo, including cell depletion and cytotoxicity studies, with particular relevance in preclinical cancer and immunology models. The correct storage temperature for sterile packaged clone B22/249 (anti-mouse H-2Db antibody) depends on the intended duration of storage:
For optimal preservation, always keep the antibody in its original sterile packaging, minimize light exposure if the antibody is conjugated to a fluorochrome, and aliquot before freezing to prevent activity loss due to freeze/thaw cycles. Most manufacturers indicate that storage at 2–8°C is suitable for a few weeks to a month, while -20°C is preferred for longer-term stability. Storing at room temperature is not recommended as it leads to degradation. The B22/249 antibody is commonly used to target the mouse MHC class I molecule H-2Db, particularly in immunology research involving antigen presentation, cytotoxicity assays, and in vivo depletion. In the literature, B22/249 is often used with a set of other antibodies or proteins to address related questions about immune cell function, phenotype, or antigen specificity. Other commonly used antibodies/proteins with B22/249 include:
Other relevant clones and closely related antibodies:
In summary, when B22/249 is used in the literature, it is commonly paired with antibodies against other MHC class I/II molecules (like H-2Kb), T cell markers (CD3, CD8, CD4), and isotype controls, depending on the experimental context. This allows researchers to comprehensively profile antigen presentation and immune cell function. Clone B22/249 is a monoclonal antibody specific for the mouse H-2D<sup>b</sup> MHC class I molecule, widely used in immunology research. Key findings from scientific literature citing clone B22/249 include the following:
In summary, B22/249 is a critical research tool for blocking or detecting mouse H-2D<sup>b</sup> MHC class I molecules, enabling detailed mechanistic studies of CD8<sup>+</sup> T cell responses in preclinical immunology models. References & Citations1. Yoshida R. Adv Immunol. 124:207-247. 2014.
2. Peng S, Mattox A, Best SR, et al. Cancer Immunol Immunother. 65(3):261-271. 2016. 3. Hammerling GJ, Hammerling U, and Lemke HL. Immunogenetics. 8:433. 1979. 4. Klein J, Huang HJS, Lemke H, et al. Immunogenetics. 8:419. 1979. 5. Maloy WL, Hämmerling G, Nathenson SG, et al. J Immunol Methods. 37(3-4):287-299. 1980. 6. Maloy WL, Coligan JE. Immunogenetics. 16(1):11-22. 1982. 7. Melino M, Nichols E, Strausser H, et al. J lmmunol. 129:222. 1982. 8. Shapiro LH, Dugan ES, Neiderhuber JE. J Exp Med. 162(5):1477-1493. 1985. Technical ProtocolsCertificate of Analysis |
Formats Available
Prod No. | Description |
---|---|
B344 | |
B345 | |
B342 | |
B343 | |
B340 | |
B346 | |
B347 | |
B348 | |
B349 | |
B341 |
